Ganirelix Acetate
- Product NDC
- 0052-0301
- 11-digit product format
- 000520301
- Labeler code
- 0052
- Product ID
- 0052-0301_21680ef9-07e9-4350-8f1b-51232fc3f0e1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ganirelix Acetate
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Organon USA Inc.
- Application
- NDA021057
- Marketing category
- NDA
- Marketing start
- 1999-07-29
- Marketing end
- 0000-00-00
- Substance
- GANIRELIX ACETATE
- Active strength
- 250 ug/.5mL
- Pharmacologic classes
- Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0052-0301-51 | 00052030151 | 1 BLISTER PACK in 1 CARTON (0052-0301-51) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS | 1 blister pack | 1999-07-29 | 0000-00-00 | No | No | Current |
| 0052-0301-81 | 00052030181 | 1 BLISTER PACK in 1 CARTON (0052-0301-81) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS | 1 blister pack | 1999-07-29 | 0000-00-00 | No | No | Current |